IT7829207A0 - Preparati farmaceutici. - Google Patents

Preparati farmaceutici.

Info

Publication number
IT7829207A0
IT7829207A0 IT7829207A IT2920778A IT7829207A0 IT 7829207 A0 IT7829207 A0 IT 7829207A0 IT 7829207 A IT7829207 A IT 7829207A IT 2920778 A IT2920778 A IT 2920778A IT 7829207 A0 IT7829207 A0 IT 7829207A0
Authority
IT
Italy
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
IT7829207A
Other languages
English (en)
Other versions
IT1100904B (it
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH546578A external-priority patent/CH642944A5/de
Priority claimed from CH546678A external-priority patent/CH639846A5/de
Priority claimed from CH940778A external-priority patent/CH644850A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IT7829207A0 publication Critical patent/IT7829207A0/it
Application granted granted Critical
Publication of IT1100904B publication Critical patent/IT1100904B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IT29207/78A 1977-10-28 1978-10-27 Preparati farmaceutici IT1100904B (it)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
LU78408 1977-10-28
LU78407 1977-10-28
CH546578A CH642944A5 (en) 1978-05-19 1978-05-19 Urea derivatives
CH546678A CH639846A5 (en) 1978-05-19 1978-05-19 Pharmaceutical preparations having antiandrogenic action, containing urea derivatives or hydantoin derivatives
CH940778A CH644850A5 (en) 1977-10-28 1978-09-07 Pharmaceutical preparations containing urea derivatives

Publications (2)

Publication Number Publication Date
IT7829207A0 true IT7829207A0 (it) 1978-10-27
IT1100904B IT1100904B (it) 1985-09-28

Family

ID=27509239

Family Applications (1)

Application Number Title Priority Date Filing Date
IT29207/78A IT1100904B (it) 1977-10-28 1978-10-27 Preparati farmaceutici

Country Status (15)

Country Link
US (1) US4234736A (it)
JP (1) JPS5473754A (it)
AU (2) AU522796B2 (it)
BE (1) BE871584A (it)
BR (1) BR7807115A (it)
CA (2) CA1138334A (it)
DE (1) DE2846945A1 (it)
DK (1) DK481778A (it)
FR (1) FR2407205A1 (it)
GB (2) GB2008101B (it)
IL (1) IL55774A (it)
IT (1) IT1100904B (it)
NL (1) NL7810562A (it)
NZ (1) NZ188720A (it)
SE (2) SE433304B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
FI801184A (fi) * 1979-04-24 1980-10-25 Hoffmann La Roche Foerfarande foer framstaellning av imidazolidinderivat
EP0091596B1 (de) * 1982-04-08 1991-09-11 Shell Internationale Researchmaatschappij B.V. Neue Hydantoine, ihre Herstellung und Verwendung
WO1990002112A1 (en) * 1988-08-23 1990-03-08 The Nutrasweet Company Substituted aryl ureas as high potency sweeteners
FR2656302B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveau procede de preparation de l'anandron et derives de l'anandron.
FR2671348B1 (fr) * 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
US5670641A (en) * 1995-06-02 1997-09-23 American Cyanamid Company 3-(3-aryloxyphenyl)-1-(substituted methyl)-S-triazine-2,4,6-oxo or thiotrione herbicidal agents
AU2001288213B2 (en) 2000-06-28 2005-04-14 Bristol-Myers Squibb Company Selective androgen receptor modulators and methods for their identification, design and use
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
EP1854798A3 (en) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
ES2310622T3 (es) 2001-12-19 2009-01-16 Bristol-Myers Squibb Company Compuestos heterociclicos condensados y analogos de los mismos, moduladores de la funcion de los receptores nucleares de hormonas.
EP2299266A1 (en) * 2003-12-19 2011-03-23 The Regents of the University of California Methods and materials for assessing prostate cancer therapies
US7718684B2 (en) * 2004-02-24 2010-05-18 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7709517B2 (en) * 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
DK2656841T3 (en) 2006-03-27 2016-12-05 Univ California Androgen receptor MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND androgen receptor-ASSOCIATED DISEASES
RU2449993C2 (ru) 2006-03-29 2012-05-10 Те Риджентс Оф Те Юниверсити Оф Калифорния Диарилтиогидантоиновые соединения
CA2966280A1 (en) 2007-10-26 2009-04-30 The Regents Of The University Of California Diarylhydantoin compounds
WO2011103202A2 (en) 2010-02-16 2011-08-25 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
KR20220025231A (ko) 2012-09-26 2022-03-03 아라곤 파마슈티컬스, 인코포레이티드 비전이성 거세 저항성 전립선암 치료용 항안드로겐
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
KR20200070334A (ko) 2017-10-16 2020-06-17 아라곤 파마슈티컬스, 인코포레이티드 비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629779A (it) *
US3134663A (en) * 1957-07-23 1964-05-26 Geigy Chem Corp Herbicidal composition and method employing hydantoins
GB997037A (en) 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
IL31416A0 (en) 1968-02-19 1969-03-27 Bayer Ag 5-imino-2-oxo-imidazolidines,their preparation and use as herbicides
SE339690B (it) * 1968-03-28 1971-10-18 Geigy Ag J R
DK123717B (da) * 1968-11-25 1972-07-24 Sumitomo Chemical Co 3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning.
US3676456A (en) * 1970-02-27 1972-07-11 Ciba Geigy Corp Derivatives of 3-aryl-5-alkylhydantoins
JPS5136332B1 (it) * 1970-12-09 1976-10-07
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
IL45459A (en) 1973-09-03 1978-01-31 Ciba Geigy Ag 1-(dichlorofluoromethylthio)-3-phenyl-imidazolidine-2,4-dione derivatives their preparation and their use as bactericides and fungicides
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant

Also Published As

Publication number Publication date
NL7810562A (nl) 1979-05-02
BE871584A (fr) 1979-04-27
DE2846945A1 (de) 1979-05-03
CA1137091A (en) 1982-12-07
CA1138334A (en) 1982-12-28
DK481778A (da) 1979-04-29
IL55774A0 (en) 1978-12-17
GB2008101B (en) 1982-09-08
SE8202106L (sv) 1982-04-01
NZ188720A (en) 1984-12-14
IL55774A (en) 1982-04-30
FR2407205A1 (fr) 1979-05-25
GB2087870A (en) 1982-06-03
SE433304B (sv) 1984-05-21
AU522796B2 (en) 1982-06-24
US4234736A (en) 1980-11-18
JPS5473754A (en) 1979-06-13
IT1100904B (it) 1985-09-28
AU4096278A (en) 1980-05-01
AU551161B2 (en) 1986-04-17
GB2087870B (en) 1982-11-10
BR7807115A (pt) 1979-05-15
SE7811193L (sv) 1979-04-29
FR2407205B1 (it) 1982-12-31
AU8105182A (en) 1982-07-08
GB2008101A (en) 1979-05-31

Similar Documents

Publication Publication Date Title
IT7829207A0 (it) Preparati farmaceutici.
NO801863L (no) Farmasoeytiske preparater.
NL7806535A (nl) Zacht werkende reinigingspreparaten.
NL182775C (nl) Corticosteroide bevattende farmaceutische preparaten.
NL7803626A (nl) 2-alkyleenaminodihydropyridinen, werkwijzen ter berei- ding ervan, alsmede farmaceutische preparaten.
IT7824084A0 (it) Preparati di coloranti.
NL7801421A (nl) Preparaten.
NL7802892A (nl) Pseudotrisacchariden, werkwijzen ter bereiding ervan en farmaceutische preparaten.
SE7809373L (sv) Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat
NL7711446A (nl) Pharmaceutische desinfecterend preparaat.
IT7825468A0 (it) Preparati di pigmento.
IT7821686A0 (it) Composizione farmaceutica.
NO147437C (no) Partikkelformig forstoff for droevtyggere.
NL7806573A (nl) Preparaten met geneeskundige werkzaamheid.
NL7801921A (nl) Farmaceutische preparaten.
NL7809626A (nl) Therapeutische preparaat.
NL7801589A (nl) Microbicide preparaten.
NL7705561A (nl) Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan.
IT1162757B (it) Preparati farmaceutici con aumentata azione ipotensiva
NL7704084A (nl) Medicinale preparaten.
NL7805158A (nl) Farmaceutisch preparaat.
NL184896C (nl) Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten.
NL7812344A (nl) Farmaceutisch preparaat.
NL7803601A (nl) Farmaceutische preparaten.
NL7613452A (nl) Farmaceutische anti-fertiliteitspreparaten.